West Pharmaceutical Services, Inc. (NYSE:WST) Shares Acquired by Clear Harbor Asset Management LLC

Clear Harbor Asset Management LLC increased its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 8.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,591 shares of the medical instruments supplier’s stock after buying an additional 1,236 shares during the period. Clear Harbor Asset Management LLC’s holdings in West Pharmaceutical Services were worth $4,680,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Fidelis Capital Partners LLC purchased a new stake in shares of West Pharmaceutical Services during the first quarter worth about $27,000. Crewe Advisors LLC increased its stake in West Pharmaceutical Services by 322.7% during the 2nd quarter. Crewe Advisors LLC now owns 93 shares of the medical instruments supplier’s stock worth $31,000 after buying an additional 71 shares in the last quarter. Northwest Investment Counselors LLC acquired a new position in shares of West Pharmaceutical Services during the third quarter valued at approximately $30,000. ORG Partners LLC lifted its position in shares of West Pharmaceutical Services by 820.0% in the first quarter. ORG Partners LLC now owns 138 shares of the medical instruments supplier’s stock valued at $55,000 after acquiring an additional 123 shares in the last quarter. Finally, Quest Partners LLC lifted its position in shares of West Pharmaceutical Services by 5,633.3% in the second quarter. Quest Partners LLC now owns 172 shares of the medical instruments supplier’s stock valued at $57,000 after acquiring an additional 169 shares in the last quarter. Institutional investors and hedge funds own 93.90% of the company’s stock.

West Pharmaceutical Services Stock Down 6.9 %

Shares of WST opened at $307.92 on Friday. The stock has a 50 day moving average price of $300.51 and a 200 day moving average price of $321.78. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.68 and a current ratio of 2.34. The stock has a market capitalization of $22.43 billion, a price-to-earnings ratio of 40.62, a PEG ratio of 10.21 and a beta of 1.01. West Pharmaceutical Services, Inc. has a one year low of $265.00 and a one year high of $413.70.

West Pharmaceutical Services (NYSE:WST) last released its earnings results on Thursday, October 24th. The medical instruments supplier reported $1.85 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.51 by $0.34. The business had revenue of $746.90 million during the quarter, compared to analyst estimates of $709.62 million. West Pharmaceutical Services had a net margin of 18.25% and a return on equity of 19.17%. The company’s revenue for the quarter was down .1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.16 earnings per share. Equities research analysts forecast that West Pharmaceutical Services, Inc. will post 6.42 earnings per share for the current fiscal year.

West Pharmaceutical Services Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, November 20th. Stockholders of record on Wednesday, November 13th will be given a $0.21 dividend. The ex-dividend date is Wednesday, November 13th. This is a positive change from West Pharmaceutical Services’s previous quarterly dividend of $0.20. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.27%. West Pharmaceutical Services’s dividend payout ratio is 11.08%.

Insider Activity at West Pharmaceutical Services

In other West Pharmaceutical Services news, VP Charles Witherspoon sold 1,029 shares of the business’s stock in a transaction on Monday, August 19th. The stock was sold at an average price of $300.00, for a total transaction of $308,700.00. Following the transaction, the vice president now owns 1,478 shares of the company’s stock, valued at approximately $443,400. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 0.53% of the company’s stock.

West Pharmaceutical Services Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.